Search Within

Eytan Moshe Stein

Formats
  1. Meeting Abstract (217)
  2. Journal Article (104)
  3. Review (17)
  4. Research Letter (14)
  5. Editorial (5)
  6. Book Section (3)
  7. Guidelines (2)
  8. Correspondence (1)
  9. Miscellaneous (1)
Groups
  1. Adult Leukemia (364)
  2. Center for Hematologic Malignancies (364)
  3. Department of Medicine (364)
  4. Hematologic Malignancies, Division of (364)
  5. GSK Faculty (92)
  6. Executive Committee, Center for Hematologic Malignancies (87)

More Groups

People
  1. Martin Tallman (116)
  2. Ross Levine (75)
  3. Aaron Goldberg (41)
  4. Jan Bewersdorf (33)
  5. Andriy Derkach (31)
  6. Christopher Famulare (30)

More People

Years
  1. 2025 (14)
  2. 2024 (44)
  3. 2023 (49)
  4. 2022 (34)
  5. 2021 (31)
  6. 2020 (30)

More Years

Publications
  1. Blood (170)
  2. Journal of Clinical Oncology (23)
  3. Clinical Lymphoma, Myeloma and Leukemia (17)
  4. Haematologica (16)
  5. Blood Advances (14)
  6. Leukemia and Lymphoma (12)

More Publications

Publishers
  1. American Society of Hematology (185)
  2. Elsevier Inc. (30)
  3. American Society of Clinical Oncology (27)
  4. Ferrata Storti Foundation (16)
  5. Nature Publishing Group (15)
  6. Taylor & Francis Group (12)

More Publishers

Results (364)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Advances in menin inhibition in acute myeloid leukemia
    Review

    Boussi, L.; Cai, S. F.; Stein, E. M.
    Trends in Cancer (2025)

    Fulltext@MSK | Save
  • Phase I first-in-human dose escalation study of the oral casein kinase 1α and cyclin dependent kinase 7/9 inhibitor BTX A51 in advanced MDS and AML
    Journal Article

    Ball, B. J.; Xiao, W.; Borthakur, G.; Nguyen, L. X. T.; Valerio, M.; Venkatachalam, A.; Marcucci, G.; Stein, A. S.; Thai, D. L.; Cook, D. N.; more...
    Journal of Hematology & Oncology (2025)

    Fulltext@MSK | Save
  • Patients with AML and an IDH2-R172 mutation exhibit a unique initial response to intensive chemotherapy induction
    Journal Article

    Yisraeli Salman, M.; Terry, A. R.; Derkach, A.; Nemirovsky, D.; Chin, K. K.; Valtis, Y. K.; Boussi, L.; Spivey, T.; Xiao, W.; Famulare, C.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • Azacitidine, venetoclax, and revumenib for newly diagnosed NPM1-mutated or KMT2A-rearranged AML
    Journal Article

    Zeidner, J. F.; Lin, T. L.; Welkie, R. L.; Curran, E.; Koenig, K.; Stock, W.; Madanat, Y. F.; Swords, R.; Baer, M. R.; Blum, W.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Barriers to chimeric antigen receptor T-cell therapy
    Research Letter

    Valtis, Y. K.; Chin, K. K.; Nemirovsky, D.; Devlin, S. M.; Yisraeli Salman, M.; Boussi, L.; Cadzin, B.; McLoughlin, C.; Cathcart, E.; Davis, P.; more...
    JAMA Oncology (2025)

    Fulltext@MSK | Save
  • Deconvoluting clonal and cellular architecture in IDH-mutant acute myeloid leukemia
    Journal Article

    Sirenko, M.; Lee, S.; Sun, Z.; Chaligne, R.; Loghavi, S.; Asimomitis, G.; Brierley, C. K.; Bernard, E.; Cai, S. F.; Myers, R. M.; more...
    Cell Stem Cell (2025)

    Fulltext@MSK | Save
  • A phase I study of FHD-286, a dual BRG1/BRM (SMARCA4/SMARCA2) inhibitor, in patients with advanced myeloid malignancies
    Journal Article

    DiNardo, C. D.; Fathi, A. T.; Kishtagari, A.; Bhalla, K. N.; Quintás-Cardama, A.; Reilly, S. A.; Almon, C.; Patriquin, C.; Nabhan, S.; Healy, K.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • Defining 2 biologically and clinically distinct groups in acute leukemia with a mixed phenotype
    Journal Article

    Galera, P.; Dilip, D.; Derkach, A.; Chan, A.; Zhang, Y.; Persaud, S.; Mishra, T.; Kramer, K.; Kathpalia, M.; Liu, Y.; more...
    Blood (2025)

    Fulltext@MSK | Save
  • Molecular characterization of newly diagnosed acute myeloid leukemia patients aged 60 years or older: A report from the Beat AML clinical trial
    Research Letter

    Hoff, F. W.; Huang, Y.; Welkie, R. L.; Swords, R. T.; Traer, E.; Stein, E. M.; Lin, T. L.; Patel, P. A.; Collins, R. H. Jr; Baer, M. R.; more...
    Blood Cancer Journal (2025)

    Fulltext@MSK | Save
  • Phase Ib study of PRT543, an oral protein arginine methyltransferase 5 (PRMT5) inhibitor, in patients with advanced splicing factor-mutant myeloid malignancies
    Research Letter

    Bewersdorf, J. P.; Mi, X.; Lu, B.; Kuykendall, A.; Sallman, D.; Patel, M.; Stevens, D.; Philipovskiy, A.; Sutamtewagul, G.; Masarova, L.; more...
    Leukemia (2025)

    Fulltext@MSK | Save